Hong Kong to India: Diagnostic Import Trade Route
India has recorded 136 verified shipments of Diagnostic imported from Hong Kong, representing a combined trade value of $413.9K USD. This corridor is served by 7 active Hong Kong exporters, with an average shipment value of $3.0K USD. The leading Hong Kong supplier is HK CHASING INTERNATIONAL TRADE CO LTD, which accounts for 64% of total import value with 2 shipments worth $262.9K USD. On the buying side, ADVY CHEMICAL PRIVATE LIMITED is the largest Indian importer with $262.9K USD in purchases. The top 3 suppliers — HK CHASING INTERNATIONAL TRADE CO LTD, FAPON INTERNATIONAL LIMITED, FAPON INTERNATIONAL LIMITED. — together control 88% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill of entry records. Values reported in FOB USD.
Route Intelligence Overview
The Hong Kong to India Diagnostic corridor is one of India's established pharmaceutical import routes from Hong Kong, with 136 shipments documented worth a combined $413.9K USD. The route is dominated by HK CHASING INTERNATIONAL TRADE CO LTD, which alone accounts for roughly 64% of all import value, reflecting the consolidated nature of Hong Kong's diagnostic export sector.
Across 7 active Hong Kong suppliers, the average shipment value stands at $3.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with diagnostic's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 22.7%, placing it at rank #15 among India's top diagnostic import origins globally.
On the Indian buyer side, key Indian importers include ADVY CHEMICAL PRIVATE LIMITED, TULIP DIAGNOSTICS PRIVATE LIMITED, Q-LINE BIOTECH PRIVATE LIMITED and 5 others. ADVY CHEMICAL PRIVATE LIMITED is the single largest Indian importer with 2 shipments valued at $262.9K USD.
Route Characteristics
- Average transit31 days
- Peak seasonQ3
- Primary modeSea freight
- Top port of entryDELHI AIR CARGO ACC (INDEL4)
Market Position
- Global rank#15
- Annual growth+22.7%
- Demand growth+19.3%
- Regulatory ease80/100
Top 10 Diagnostic Exporters from Hong Kong to India
Showing top 10 of 7 Hong Kong suppliers exporting Diagnostic to India, ranked by total trade value (USD)
| Rank | Supplier (Hong Kong Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | HK CHASING INTERNATIONAL TRADE CO LTD Avg $131.4K per shipment | 2 | $262.9K | 63.5% |
| 2 | FAPON INTERNATIONAL LIMITED Avg $3.8K per shipment | 15 | $56.7K | 13.7% |
| 3 | FAPON INTERNATIONAL LIMITED. Avg $846 per shipment | 51 | $43.2K | 10.4% |
| 4 | FAPON INTERNATIONAL LTD. Avg $1.3K per shipment | 20 | $26.8K | 6.5% |
| 5 | FAPON INTERNATIONAL LTD Avg $908 per shipment | 24 | $21.8K | 5.3% |
| 6 | FAPON INTERNATIONAL LTD Avg $211 per shipment | 8 | $1.7K | 0.4% |
| 7 | SENBT CO.,LTD Avg $52 per shipment | 16 | $827 | 0.2% |
This table shows the top 10 of 7 Hong Kong companies exporting diagnostic to India, ranked by total trade value. The listed exporters are: HK CHASING INTERNATIONAL TRADE CO LTD, FAPON INTERNATIONAL LIMITED, FAPON INTERNATIONAL LIMITED., FAPON INTERNATIONAL LTD., FAPON INTERNATIONAL LTD, FAPON INTERNATIONAL LTD , SENBT CO.,LTD . HK CHASING INTERNATIONAL TRADE CO LTD is the dominant supplier with 2 shipments worth $262.9K USD, giving it a 64% market share. The top 3 suppliers together account for 88% of the total trade value on this route.
Top 10 Indian Diagnostic Importers from Hong Kong
Showing top 10 of 8 known Indian buyers receiving Diagnostic shipments from Hong Kong, ranked by import value
On the receiving end of this trade route, the leading Indian importers of Hong Kong diagnostic include ADVY CHEMICAL PRIVATE LIMITED, TULIP DIAGNOSTICS PRIVATE LIMITED, Q-LINE BIOTECH PRIVATE LIMITED, ARKRAY HEALTHCARE PRIVATE LIMITED, BIOLINE DIAGNOSTICS LLP, among 8 total buyers. The largest importer is ADVY CHEMICAL PRIVATE LIMITED, accounting for $262.9K USD across 2 shipments — representing 64% of all diagnostic imports from Hong Kong on this route.
| Rank | Indian Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ADVY CHEMICAL PRIVATE LIMITED | 2 | $262.9K | 63.5% |
| 2 | TULIP DIAGNOSTICS PRIVATE LIMITED | 12 | $56.5K | 13.7% |
| 3 | Q-LINE BIOTECH PRIVATE LIMITED | 51 | $43.2K | 10.4% |
| 4 | ARKRAY HEALTHCARE PRIVATE LIMITED | 20 | $26.8K | 6.5% |
| 5 | BIOLINE DIAGNOSTICS LLP | 24 | $21.8K | 5.3% |
| 6 | BIOLINE DIAGNOSTICS LLP | 8 | $1.7K | 0.4% |
| 7 | AGAPPE DIAGNOSTICS LIMITED | 16 | $827 | 0.2% |
| 8 | LABGENE BIO-TECH PRIVATE LIMITED | 3 | $200 | 0.0% |
Top 10 Diagnostic Formulations Imported from Hong Kong
Showing top 10 of 114 product formulations shipped on the Hong Kong to India Diagnostic route, ranked by trade value
India imports a wide range of diagnostic formulations from Hong Kong, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — HBSAG REAGENT (Diagnostic Reagents) HBSAG REAGENT (Diagnostic Reagents) — accounts for $262.9K USD across 2 shipments. There are 114 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | HBSAG REAGENT (Diagnostic Reagents) HBSAG REAGENT (Diagnostic Reagents) | 2 | $262.9K | 63.5% |
| 2 | RECOMBINANT ANTIGEN (BULK DRUG TO BE USED FOR MFG DIAGNOSTICKIT FOR HCV), CAT#GRCHCVS303, 500 MGRECOMBINANT ANTIGEN (BULK DRUG TO BE USED FOR MFG DIAGNOSTIC | 1 | $21.3K | 5.2% |
| 3 | RECOMBINANT ANTIGEN (BULK DRUG TO BE USED FOR MFG DIAGNOSTICKIT FOR HCV), CAT#GRJCPS202, 500 MGRECOMBINANT ANTIGEN (BULK DRUG TO BE USED FOR MFG DIAGNOSTIC | 1 | $21.3K | 5.2% |
| 4 | RECOMBINANT ANTIGEN (BULK DRUG TO BE USED FOR MFG DIAGNOSTICKIT FOR HCV), CAT#GRJHCVS205, 220 MGRECOMBINANT ANTIGEN (BULK DRUG TO BE USED FOR MFG DIAGNOSTIC | 1 | $9.4K | 2.3% |
| 5 | RECOMBINANT ANTIGEN GRCHCVS303/RAW MATERIAL FOR MANUFACTURING OF DIAGNOSTIC KITRAW MATERIAL FOR MANUFACTURING OF DIAGNOSTIC KIT | 1 | $8.8K | 2.1% |
| 6 | MONOCLONAL ANTIBODY BRCMALS105/RAW MATERIAL FOR MANUFACTURING OF DIAGNOSTIC KITRAW MATERIAL FOR MANUFACTURING OF DIAGNOSTIC KIT | 2 | $6.6K | 1.6% |
| 7 | RECOMBINANT ANTIGEN GRJHIVS202 (MFG OF DIAGNOSTICS KIT FOR DETECTION OF Crystal HIV-1/2 IN PATHOLOGICAL USE)Monoclonal Antibody | 1 | $6.3K | 1.5% |
| 8 | GRCHIVS105 RECOMBINANT ANTIGEN, (ANTIBODY)(RAW MATERIAL FOR MANUFACTURING OF DIAGNOSTIC KIT)GRCHIVS105 RECOMBINANT ANTIGEN, (ANTIBODY) | 2 | $4.9K | 1.2% |
| 9 | RECOMBINANT ANTIGEN (BULK DRUG TO BE USED FOR MFG DIAGNOSTICKIT FOR HCV), CAT#GRJCPS202, 100 MGRECOMBINANT ANTIGEN (BULK DRUG TO BE USED FOR MFG DIAGNOSTIC | 1 | $4.3K | 1.0% |
| 10 | MONOCLONAL ANTIBODY BRCMALS213/RAW MATERIAL FOR MANUFACTURING OF DIAGNOSTIC KITRAW MATERIAL FOR MANUFACTURING OF DIAGNOSTIC KIT | 2 | $3.9K | 0.9% |
Showing top 10 of 114 Diagnostic formulations imported from Hong Kong on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 77%, typical for bulk pharmaceutical shipments.
Top Indian Ports of Entry
DELHI AIR CARGO ACC (INDEL4) handles the highest volume with 83 shipments. Transit time averages 31 days by sea.
Market Dynamics
India's diagnostic imports from Hong Kong are driven primarily by a handful of large-scale Hong Kong manufacturers. HK CHASING INTERNATIONAL TRADE CO LTD with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — Indian buyers benefit from Hong Kong supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — HK CHASING INTERNATIONAL TRADE CO LTD, FAPON INTERNATIONAL LIMITED, FAPON INTERNATIONAL LIMITED. — together account for 88% of total trade value on this route. The average shipment value of $3.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as recombinant antigen (bulk drug to be used for mfg diagnostickit for hcv), cat#grchcvs303, 500 mgrecombinant antigen (bulk drug to be used for mfg diagnostic and recombinant antigen (bulk drug to be used for mfg diagnostickit for hcv), cat#grjcps202, 500 mgrecombinant antigen (bulk drug to be used for mfg diagnostic, suggesting that Indian buyers tend to consolidate orders across related product lines from the same Hong Kong supplier.
On the buying side, ADVY CHEMICAL PRIVATE LIMITED is the largest importer with 2 shipments worth $262.9K USD — representing 64% of all diagnostic imports from Hong Kong on this route. A total of 8 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $413.9K
- Avg. Shipment
- $3.0K
- Suppliers
- 7
- Buyers
- 8
- Transit (Sea)
- ~31 days
- Annual Growth
- +22.7%
Related Analysis
Unlock the Full Hong Kong to India Diagnostic Dataset
TransData Nexus provides verified shipment-level records, exporter contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 136 shipments on this route.
Frequently Asked Questions — Hong Kong to India Diagnostic Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Hong Kong companies export Diagnostic to India?
The leading Hong Kong exporters of Diagnostic to India are HK CHASING INTERNATIONAL TRADE CO LTD, FAPON INTERNATIONAL LIMITED, FAPON INTERNATIONAL LIMITED.. HK CHASING INTERNATIONAL TRADE CO LTD holds the largest market share at approximately 64% of total trade value on this route.
Q What is the total value of Diagnostic imports from Hong Kong to India?
India imports Diagnostic from Hong Kong worth approximately $413.9K USD across 136 recorded shipments. The average value per shipment is $3.0K USD.
Q Which Indian ports receive Diagnostic from Hong Kong?
The most active Indian port of entry is DELHI AIR CARGO ACC (INDEL4) with 83 shipments. Hong Kong exporters primarily use sea freight for this route, with 77% of shipments going by sea and 24% by air.
Q How long does shipping take from Hong Kong to India for Diagnostic?
The average transit time for Diagnostic shipments from Hong Kong to India is approximately 31 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the Hong Kong to India Diagnostic import route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 22.7% with demand growth tracking at 19.3%. The route is ranked #15 among India's top Diagnostic import origins globally.
Q How many Hong Kong suppliers are active on this Diagnostic import route?
There are currently 7 active Hong Kong suppliers exporting Diagnostic to India. The market is moderately concentrated with HK CHASING INTERNATIONAL TRADE CO LTD accounting for 64% of total shipment value.
Q Who are the main Indian importers of Diagnostic from Hong Kong?
The leading Indian importers of Diagnostic from Hong Kong include ADVY CHEMICAL PRIVATE LIMITED, TULIP DIAGNOSTICS PRIVATE LIMITED, Q-LINE BIOTECH PRIVATE LIMITED, ARKRAY HEALTHCARE PRIVATE LIMITED, BIOLINE DIAGNOSTICS LLP. ADVY CHEMICAL PRIVATE LIMITED is the largest buyer with 2 shipments worth $262.9K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Hong Kong export trade corridor identified from Indian Customs (DGFT) records for Diagnostic.
- 2.Supplier/Buyer Matching: 7 Indian exporters and 8 importers in Hong Kong matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 136 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
136 Verified Shipments
7 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists